Clinical Roundup Imfinzi regimen reduced early disease recurrence in non-muscle-invasive bladder cancer, phase III trial POTOMAC shows May 22, 2026Vol.52 No.20
Clinical Roundup Perioperative Imfinzi + neoadjuvant EV improved EFS and OS in muscle-invasive bladder cancer, phase III VOLGA trial shows May 22, 2026Vol.52 No.20
Clinical Roundup Intismeran cancer vaccine + Keytruda sustains 49% melanoma reduction after five years May 22, 2026Vol.52 No.20
Clinical Roundup Phase III trial of sacituzumab tirumotecan met primary endpoints in advanced or recurrent endometrial cancer May 22, 2026Vol.52 No.20
Clinical Roundup PSMAddition data show 58% lower risk of PSA progression with Pluvicto in metastatic hormone-sensitive prostate cancer May 22, 2026Vol.52 No.20
Clinical Roundup USC comparison study of leading targeted therapies for ALK+ lung cancer could lead to better treatment decisions May 22, 2026Vol.52 No.20
Clinical Roundup UTSW researchers identify central signaling pathway that enables survival without the need for genetic change May 22, 2026Vol.52 No.20
Clinical Roundup Lab study reveals patterns of inheritance that defy Mendel’s Laws May 22, 2026Vol.52 No.20
Clinical Roundup Winship first in U.S. to administer in vivo CAR-T therapy in myeloma trial May 22, 2026Vol.52 No.20
Clinical Roundup Stage 4 breast cancer has increased in incidence and proportion over the last decade May 15, 2026Vol.52 No.19
